Almeda Ventures LP (XTAE:AMDA) ROE %: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:AMDA Almeda Ventures LP XTAE:AMDA
10 GF Score
Price ₪2.45
! 1 Warning Sign
View Full Analysis

What is Almeda Ventures LP ROE %?

Almeda Ventures LP XTAE:AMDA -0.16% 10 ROE % is 0.00% as of . 20. GuruFocus rates XTAE:AMDA with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 628 Healthcare Providers & Services companies, Almeda Ventures LP ranks worse than 159235.51% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Almeda Ventures LP's annualized net income for the quarter that ended in . 20 was ₪ Mil. Almeda Ventures LP's average Total Stockholders Equity over the quarter that ended in . 20 was ₪ Mil. Therefore, Almeda Ventures LP's annualized ROE % for the quarter that ended in . 20 was %.

The historical rank and industry rank for Almeda Ventures LP's ROE % or its related term are showing as below:

XTAE:AMDA's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 6.15
* Ranked among companies with meaningful ROE % only.

Almeda Ventures LP  (XTAE:AMDA) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=( / )*( / )*( / )
=Net Margin %*Asset Turnover*Equity Multiplier
= %**
=ROA %*Equity Multiplier
= %*
= %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= ( / ) * ( / ) * ( / ) * ( / ) * ( / )
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= * * % * *
= %

Note: The net income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Almeda Ventures LP ROE % Related Terms


Almeda Ventures LP ROE % Historical Data

* Premium members only.

The historical data trend for Almeda Ventures LP's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almeda Ventures LP ROE % Chart

Almeda Ventures LP Annual Data
Trend
ROE %

Almeda Ventures LP Semi-Annual Data
ROE %

XTAE:AMDA vs VEEV, BTSG, HQY: ROE % Comparison

For the Health Information Services subindustry, Almeda Ventures LP's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Almeda Ventures LP ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Almeda Ventures LP's ROE % distribution charts can be found below:

* The bar in red indicates where Almeda Ventures LP's ROE % falls into.


XTAE:AMDA
10GF Score
Almeda Ventures LP XTAE:AMDA
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Almeda Ventures LP ROE % Calculation

Almeda Ventures LP's annualized ROE % for the fiscal year that ended in . 20 is calculated as

ROE %=Net Income (A: . 20 )/( (Total Stockholders Equity (A: . 20 )+Total Stockholders Equity (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Almeda Ventures LP's annualized ROE % for the quarter that ended in . 20 is calculated as

ROE %=Net Income (Q: . 20 )/( (Total Stockholders Equity (Q: . 20 )+Total Stockholders Equity (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (. 20) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
Almeda Ventures LP (XTAE:AMDA) has a ROE % of 0.00% as of . 20. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Almeda Ventures LP and its competitors. According to the industry distribution chart, Almeda Ventures LP ranks #999999 out of 628 companies in the Healthcare Providers & Services industry.
Is Almeda Ventures LP's ROE % too high?
Almeda Ventures LP's current ROE % is 0.00%. Based on the distribution chart, Almeda Ventures LP ranks #999999 out of 628 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Almeda Ventures LP has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Almeda Ventures LP's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Almeda Ventures LP ranks #999999 out of 628 companies for ROE %. This places Almeda Ventures LP in the lower half of its industry. The industry median ROE % is 6.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 6.15, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Almeda Ventures LP and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 6.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almeda Ventures LP's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almeda Ventures LP stock overvalued right now?
Almeda Ventures LP (XTAE:AMDA) has a current ROE % of 0.00%. The current ROE % is 0.00%. Almeda Ventures LP's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Almeda Ventures LP (XTAE:AMDA), the current ROE % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Almeda Ventures LP Business Description

Address 132 Menachem Begin Road, Azrieli Center, Triangle Tower, 45th Floor, Tel Aviv, ISR, 67023
Almeda Ventures LP is a life science research and development company. The company invests in Medical devices and Digital health businesses. Its portfolio includes BioProtect, which developed a proprietary technology platform for biodegradable balloons. The technology suits a range of clinical applications, including spacing for radiation oncology protection and general surgery. TailorMed technology improves the financial performance of healthcare providers and reduces financial hardship for patients.
10GF Score

Get the complete analysis for XTAE:AMDA

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪2.45
Price